There are multiple key players, including oncology nurses, in the treatment of patients with myelodysplastic syndrome.
It takes a team to treat patients with myelodysplastic syndrome (MDS), explained Nancy Corbitt, BSN, RN, OCN, CRNI, survivorship nurse navigator at the University of Maryland Greenbaum Cancer Center and member of the AAMDS International Foundation.
At the ONS Annual Congress, Corbitt discussed some of the key players in caring for those with MDS. They include the physician, who will discuss diagnosis and treatments, the oncology nurses who often focus on adverse event management, as well as palliative and advanced care planning specialists.
Maintenance Avelumab Has Similar Efficacy in Real World for Urothelial Cancer
March 5th 2024Patients with metastatic urothelial cancer treated with frontline maintenance therapy with avelumab following platinum-based chemotherapy in the real-world setting had similar outcomes as observed in the JAVELIN Bladder 100 trial.